EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,848 | -61.8% | 2,400 | -52.9% | 0.00% | -50.0% |
| Q2 2023 | $99,144 | -30.9% | 5,100 | +0.9% | 0.01% | -40.0% |
| Q1 2023 | $143,467 | +226.1% | 5,057 | +197.5% | 0.01% | +233.3% |
| Q3 2022 | $44,000 | +388.9% | 1,700 | +655.6% | 0.00% | +200.0% |
| Q3 2020 | $9,000 | 0.0% | 225 | +74.4% | 0.00% | 0.0% |
| Q2 2018 | $9,000 | – | 129 | +1190.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 10 | -98.9% | 0.00% | -100.0% |
| Q4 2015 | $80,000 | +3.9% | 913 | -4.9% | 0.01% | 0.0% |
| Q2 2015 | $77,000 | -24.5% | 960 | -60.6% | 0.01% | -44.0% |
| Q1 2015 | $102,000 | – | 2,435 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |